000 | 01917 a2200577 4500 | ||
---|---|---|---|
005 | 20250517174214.0 | ||
264 | 0 | _c20180905 | |
008 | 201809s 0 0 eng d | ||
022 | _a2072-6643 | ||
024 | 7 |
_a10.3390/nu9091037 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aQin, Yu | |
245 | 0 | 0 |
_aCapsaicin Supplementation Improved Risk Factors of Coronary Heart Disease in Individuals with Low HDL-C Levels. _h[electronic resource] |
260 |
_bNutrients _cSep 2017 |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 |
_aC-Reactive Protein _xanalysis |
650 | 0 | 4 |
_aCapsaicin _xadministration & dosage |
650 | 0 | 4 |
_aCholesterol Ester Transfer Proteins _xblood |
650 | 0 | 4 |
_aCholesterol, HDL _xblood |
650 | 0 | 4 |
_aCholesterol, LDL _xblood |
650 | 0 | 4 |
_aCoronary Disease _xblood |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xdrug effects |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Compliance |
650 | 0 | 4 |
_aPhosphatidylcholine-Sterol O-Acyltransferase _xblood |
650 | 0 | 4 |
_aPhospholipid Transfer Proteins _xblood |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSerum Amyloid A Protein _xanalysis |
650 | 0 | 4 |
_aTriglycerides _xblood |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
650 | 0 | 4 |
_agamma-Glutamyltransferase _xblood |
700 | 1 | _aRan, Li | |
700 | 1 | _aWang, Jing | |
700 | 1 | _aYu, Li | |
700 | 1 | _aLang, He-Dong | |
700 | 1 | _aWang, Xiao-Lan | |
700 | 1 | _aMi, Man-Tian | |
700 | 1 | _aZhu, Jun-Dong | |
773 | 0 |
_tNutrients _gvol. 9 _gno. 9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3390/nu9091037 _zAvailable from publisher's website |
999 |
_c27584673 _d27584673 |